Prognostic Significance of Ezrin Expression in Invasive Ductal Carcinoma of Breast
樊祥山,余慧萍,孟凡青,周强,吴鸿雁,周祀乔
DOI: https://doi.org/10.3969/j.issn.1672-4992.2008.07.023
2008-01-01
Journal of Modern Oncology
Abstract:Objective:To explore the expression of ezrin in benign and invasive ductal carcinoma(IDC) samples of breast,and to analyse the correlation between ezrin expression and clinopathologic features such as age, maximum diameter of mass, TNM staging, differentiation, lymph node metastasis and expression of ER, PR, c-erbB-2, MMP-2, MMP-9, E-cadherin and so on in IDC. Methods: Ezrin and ER, PR, c-erbB-2, MMP-2, MMP-9, E-cadherin protein expression were assessed on a tissue microarray containing 101 IDC cases and 29 fibroadenoma cases, 8 adenosis cases. Furthermore, age, maximum diameter of mass, TNM staging, differentiation, lymph node metastasis and so on were analyzed. Results: The subcellular distribution of ezrin protein in benign and malignant breast lesions were significantly different. Ezrin protein localized at inner margin of the glandular tube in 91.89%(34/37) benign breast lesions, and no cytoplasm staining was observed; however, in 75.25%(76/101)of IDC cases, cytoplasm localizing of ezrin protein was observed, and inner margin staining of the glandular tube was observed in none case. In IDC cases, ezrin expression was positively related with maximum diameter (r=0.277, P=0.005), TNM stage(r=0.334, P=0.001), lymph-node metastases(r=0.323, P=0.001) , expression of MMP-9(r=0.246, P=0.013) in stromal cells. However, there was no significant relation between ezrin expression and age, histology grading and expression of ER, PR, c-erbB-2, MMP-2, MMP-9 in carcinoma cells as well as expression of MMP-2 in stroma cells. Conclusion: Ezrin protein localization in breast benign epithelial cells and carcinoma cells are remarkably different. It can be as a useful marker assisting the differential diagnosis of benign and malignant lesions in breast tumors. High expression level of ezrin in IDC suggests more aggressive and higher risk of lymph node metastasis.